HCM Medical B.V.

HCM Medical, based in the Netherlands, specializes in contract manufacturing, focusing on the development and production of advanced medical products aimed at enhancing patient care. Founded in 2014 and headquartered in Nijmegen, Netherlands, HCM Medical specializes in contract manufacturing for the medical sector. The company has completed one deal, with the most recent transaction taking place on August 20, 2025, when LifeNet Health, Inc. , a portfolio company of EXOR, acquired HCM Medical.

Financial terms of the transaction were not disclosed. HCM Medical specializes in contract manufacturing focused on the development and production of advanced medical products. The core services offered by the company include the use of Freeze Drying technology, which is integral to the production of tissue constructs. This innovative process allows for the creation of high-tech medical solutions designed to enhance patient care and improve quality of life.

The company collaborates closely with its customers, who consist of healthcare providers and medical device manufacturers, to tailor products that address specific clinical needs. HCM Medical serves a diverse clientele across various geographical markets, including Europe, North America, and Asia, ensuring that their sophisticated medical solutions are accessible to healthcare professionals worldwide. HCM Medical generates revenue through a structured business model centered around B2B transactions, primarily engaging with healthcare organizations and medical device manufacturers. The company establishes partnerships that facilitate long-term contracts for the provision of custom medical products and services.

Clients procure specific medical solutions, which may include proprietary products developed through HCM Medical's advanced manufacturing processes. Although precise pricing plans for individual services or products are not disclosed, the revenue structure is built upon the delivery of tailored solutions that meet the unique demands of their clients in the medical sector, fostering sustained relationships and contributing to consistent revenue streams. HCM Medical plans to enhance its product development capabilities following its acquisition by LifeNet Health, Inc. The company is expected to utilize this acquisition to support the launch of new medical products and expand into new markets.

Specific regions targeted for expansion include North America and Asia by the end of 2025. The recent acquisition is aimed at bolstering HCM Medical's innovation in medical solutions.